Low therapeutic value drugs: impact of limiting prescription

被引：0
|
作者：
Soler-Rodenas, A. [1 ]
Gonzalez-Muniz, V. [1 ]
Manez, E. Gil [1 ]
Rodriguez, E. Gea [1 ]
机构：
[1] Hosp Nostra Senyora Meritxell, Escaldes Engordany, Andorra
来源：
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY | 2013年 / 35卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：972 / 972
页数：1
相关论文
共 50 条
  • [31] EFFICIENCY IN THE PRESCRIPTION OF DRUGS. IMPACT OF A HEALTH POLICY: AUTOMATIC CHANGE TO PRESCRIPTION BY ACTIVE INGREDIENT
    Elizondo Lopez De landache, Isabel
    Braceras Izaguirre, Leire
    Echeto Garcia, Ainara
    Gardeazabal Romillo, Maria Jose
    Acevedo Heranz, Paloma
    REVISTA ROL DE ENFERMERIA, 2013, 36 (11): : 49 - 52
  • [32] The Economic Impact of a Switch From Prescription-Only to Non-prescription Drugs in Italy
    Otto, Monica Hildegard
    Pillarella, Carla
    Jommi, Claudio
    FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [33] CLINICAL TRIAL OF THE THERAPEUTIC VALUE OF CERTAIN ANTIRHEUMATIC DRUGS
    VANDERMEER, P
    DENOUDSTEN, SA
    ANNALS OF THE RHEUMATIC DISEASES, 1960, 19 (03) : 251 - 256
  • [34] Potential therapeutic value of drugs in Mexico: the case of antibiotics
    Mino-Leon, Dolores
    Hernandez-Caryajal, Ixzel
    Peredo-Silva, Luis
    Burbano-Martinez, Gabriel
    GACETA MEDICA DE MEXICO, 2019, 155 (01): : 15 - 19
  • [35] Therapeutic Impact of Exercise on Psychiatric DiseasesGuidelines for Exercise Testing and Prescription
    Tim Meyer
    Andreas Broocks
    Sports Medicine, 2000, 30 : 269 - 279
  • [36] THE IMPACT OF MODIFICATIONS OF THE FORMULA FOR GENERIC DRUG PRESCRIPTION RATE ON THE SWITCH TO NEW BRAND-NAME DRUGS WITH SIMILAR THERAPEUTIC USES
    Shimizu, S.
    Imai, S.
    Ishikawa, K. B.
    Ikeda, S.
    Fushimi, K.
    VALUE IN HEALTH, 2014, 17 (07) : A499 - A499
  • [37] The impact of increasing patient prescription drug cost sharing on therapeutic classes of drugs received and on the health status of elderly HMO members
    Johnson, RE
    Goodman, MJ
    Hornbrook, MC
    Eldredge, MB
    HEALTH SERVICES RESEARCH, 1997, 32 (01) : 103 - 122
  • [38] Prevalence and Therapeutic Classifications of FDA-Approved Prescription Drugs With Boxed Warnings
    Cheng, Christine M.
    DeLizza, Colleen
    Kapusnik-Uner, Joan
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2014, 48 (02) : 165 - 172
  • [39] TARGETING INTERVENTIONS AT SUBSTANCE-ABUSE PROBLEMS - ACCIDENTS AND THERAPEUTIC PRESCRIPTION DRUGS
    EVERITT, DE
    AVORN, J
    PUBLIC HEALTH REPORTS, 1987, 102 (06) : 620 - 622
  • [40] Prevalence and Therapeutic Classifications of FDA-Approved Prescription Drugs With Boxed Warnings
    Christine M. Cheng
    Colleen DeLizza
    Joan Kapusnik-Uner
    Therapeutic Innovation & Regulatory Science, 2014, 48 : 165 - 172
12345